Cholesterol crystals in BAL fluid from patients with idiopathic pulmonary fibrosis

Respiratory Medicine

Volumn 90, Issue 6, 1996, Pages 361-363

  Fireman, E ^a   Spitzer, S ^b   Grief, J ^a   Kivity, S ^a   Topilsky, M ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CHOLESTEROL; PHOSPHOLIPID;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CRYSTAL; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; PRIORITY JOURNAL;

EID: 0030017382     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(96)90134-1     Document Type: Article

References (15)

1. Robinson PC, Watters LC, King TE, Mason RJ. Idiopathic pulmonary fibrosis: abnormalities in bronchoalveolar lavage fluid phospholipids. Am Rev Respir Dis 1988; 137: 585-591.
2. Reynolds HY, Chretien J. Respiratory tract fluids: analysis of content and contemporary use in understanding lung diseases. Disease a Month February 1984: 30-35.
3. Fireman E, Ben Efraim S, Messer G, Dabush S, Greif J, Topilsky M. Cell free supernatant of sarcoid alveolar macrophages suppress proliferation of sarcoid alveolar fibroblasts. Clin Immunol Immunopathol 1991; 59: 368-378.
4. Fireman E, Vardinon N, Burke M et al. The value of T lymphocytes subtypes analysis on diffuse interstitial fibrosis (Submitted).
5. Folch J, Lees M, Sloane Stanley HC. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
6. Abbel LL, Levy BB, Brodie BB, Kendal EE. A simplified method for the estimation of total cholesterol in serum demonstration of its specificity. J Biol Chem 1952; 195: 357-366.
7. Bartlett GR. Phosphorus assay by column chromatography. J Biol Chem 1959; 234: 466-468.
8. Wilsher ML, Hughes DA, Haslam PL. Immunoregulatory properties of pulmonary surfactant: effect of lining fluid of proliferation on human blood lymphocytes. Thorax 1988; 43: 354-359.
9. Wilsher ML, Hughes DA, Haslam PL. Immunoregulatory properties of pulmonary surfactant: influence of variation in the phospholipid profile. Clin Exp Immunol 1988; 73: 117-1222.
10. Hughes DA, Townsend PJ, Haslam PL. Enhancement of antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanism in extrinsic allergic alveolitis and atherosclerosis. Clin Exp Immunol 1992; 87: 279-286.
11. Hasleton PS, O'Driscoll, Lynch P et al. Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma. J Pathol 1991; 164: 31-36.
12. Wick G, Scett G, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease? Immunology Today 1995; 16: 27-33.
13. Stary HC, Chandler B, Dismore RE et al. A definition of advanced types of atherosclerotic lesions and the histological classification of atherosclerosis. Circulation 1995; 92: 1355-1374.
14. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix degrading proteinases. Proc Natl Acad Sci 1995; 92: 402-406.
15. Rosenfeld ME, Khoo JC, Miller E, Parthasarathy S, Palinsky W, Witstum JL. Macrophages-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest 1991; 87: 90-99.